Pharmaceutical Executive, November 2016 Issue (PDF)

Navigating technology and regulatory shifts in pharma revenue management.

LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.

Five steps for organizations in bringing enterprise-level strategies to life.

Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

The company shifted several key presidents to adjust its global priorities.